Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Michael J. B. Kutryk"'
Publikováno v:
Stem Cells International, Vol 2022 (2022)
Endothelial cell (EC) dysfunction has been implicated in a variety of pathological conditions. The collection of ECs from patients is typically conducted postmortem or through invasive procedures, such as surgery and interventional procedures, hamper
Externí odkaz:
https://doaj.org/article/884abb813a6c4fd2b61e4f80112112d4
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 181:218-226
This study was designed to test the ability of ex vivo antibody-coated intravascular devices to capture genetically engineered pig endothelial colony-forming cells (ECFCs) as proof of concept for their potential for in vivo targeted drug delivery. Hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d70e4b7f023e45e0bb7368bc140a0c
https://doi.org/10.1016/j.ejpb.2022.11.015
https://doi.org/10.1016/j.ejpb.2022.11.015
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 5
Pages: 4916
Volume 24
Issue 5
Pages: 4916
Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease characterized by aberrant angiogenesis and vascular malformations. Mutations in the transforming growth factor beta co-receptor, endoglin (ENG), account for approximately half of k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0c6004742dffbe17f820081657ef7e
Publikováno v:
Genes; Volume 13; Issue 4; Pages: 665
Background. Hereditary hemorrhagic telangiectasia (HHT) is a rare, autosomal dominant genetic disorder characterized by life-threatening vascular dysplasia. Myeloid angiogenic cells (MACs), alternatively called early endothelial progenitor cells or c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09dd73b56af06a4c05123b3b64652961
https://doi.org/10.3390/genes13040665
https://doi.org/10.3390/genes13040665
Publikováno v:
Molecular and cellular biochemistry. 462(1-2)
MicroRNAs (miRNAs) regulate a wide range of cellular processes and functions. Blood mononuclear cells (BMNCs) participate in the immune response, inflammatory reaction and angiogenesis. In 2010, a total of 157 miRNAs were quantified by RT-qPCR and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::321e87a7a3316118453b82284c572bc5
https://pubmed.ncbi.nlm.nih.gov/31485855
https://pubmed.ncbi.nlm.nih.gov/31485855
Autor:
Willem J. van der Giessen, Marcel van den Brand, Patrick W. Serruys, David P. Foley, Nico Bruining, Jaap N. Hamburger, Michael J B Kutryk, Pim J. deFeyter, Manel Sabaté
Publikováno v:
Journal of the American College of Cardiology. 39(2):281-287
Objectives This study was designed to determine whether antisense oligodeoxynucleotides (ODN) directed against the nuclear proto-oncogene c-myc could inhibit restenosis when given by local delivery immediately after coronary stent implantation. Backg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fada097ec6a6cd071ca0e4c01b34dd47
Publikováno v:
Thrombosis and Haemostasis. 78:367-376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eff00e2cdb3dfa6596a475dfd01bfd5f
https://doi.org/10.1055/s-0038-1657554
https://doi.org/10.1055/s-0038-1657554
Autor:
Asim N, Cheema, Sanjit S, Jolly, Jason M, Burstein, Waseem, Sharieff, Atif, Mohammad, Eunice, Yeoh, G B John, Mancini, Warren J, Cantor, Michael J B, Kutryk, Bradley H, Strauss, Robert J, Chisholm
Publikováno v:
Journal of interventional cardiology. 26(2)
Long-term outcome after bifurcation stenting with drug-eluting stents (DES) for obstructive coronary artery disease is poorly understood. In this study, we report 6-9-month angiographic follow-up and long-term clinical outcomes after implantation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0fb524954443eeaefc4827fab96c72ef
https://pubmed.ncbi.nlm.nih.gov/23406435
https://pubmed.ncbi.nlm.nih.gov/23406435
Autor:
Ravi R, Bajaj, Atif, Mohammad, Tony, Hong, Affan, Irfan, Waseem, Sharieff, Alan, Bagnall, Jo-Ann, Christie, Michael J B, Kutryk, Robert J, Chisholm, Asim N, Cheema
Publikováno v:
The Journal of invasive cardiology. 22(8)
Adjunctive administration of the glycoprotein IIb/IIIa platelet receptor antagonist (GPA), abciximab, improves outcomes in patients undergoing rescue percutaneous coronary intervention (PCI). However, it is unknown if other GPAs provide a similar ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9140fa31f1765fe0ad532581e246cf49
https://pubmed.ncbi.nlm.nih.gov/20679668
https://pubmed.ncbi.nlm.nih.gov/20679668
Autor:
Duncan J, Stewart, Michael J B, Kutryk, David, Fitchett, Michael, Freeman, Nancy, Camack, Yinghua, Su, Anthony, Della Siega, Luc, Bilodeau, Jeffrey R, Burton, Guy, Proulx, Sam, Radhakrishnan, Timothy, Ramsay
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 17(6)
Despite the promise of proangiogenic gene therapy most clinical trials have failed to show benefit for the primary end point analysis. The NOGA angiogenesis Revascularization Therapy: assessment by RadioNuclide imaging (NORTHERN) trial was a double-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce61ceac85a3b68f90b24dac018ec5d
https://pubmed.ncbi.nlm.nih.gov/19352324
https://pubmed.ncbi.nlm.nih.gov/19352324